Home / EIF3K Knockout Cell Lines

EIF3K Knockout Cell Lines

Gene: EIF3K

Official Full Name: eukaryotic translation initiation factor 3 subunit Kprovided by HGNC

Gene Summary: The 700-kD eukaryotic translation initiation factor-3 (eIF3) is the largest eIF and contains at least 12 subunits, including EIF2S12. eIF3 plays an essential role in translation by binding directly to the 40S ribosomal subunit and promoting formation of the 40S preinitiation complex (Mayeur et al., 2003 [PubMed 14519125]).[supplied by OMIM, Mar 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO27634 EIF3K Knockout cell line (HeLa) Human EIF3K 1:3~1:6 Negative Online Inquiry
KO27635 EIF3K Knockout cell line (HCT 116) Human EIF3K 1:2~1:4 Negative Online Inquiry
KO27636 EIF3K Knockout cell line (HEK293) Human EIF3K 1:3~1:6 Negative Online Inquiry
KO27637 EIF3K Knockout cell line (A549) Human EIF3K 1:3~1:4 Negative Online Inquiry

Background

EIF3K Gene Knockout Cell Lines are specialized biological tools that enable researchers to investigate the role of the eukaryotic translation initiation factor 3 subunit K (EIF3K) in various cellular processes. These cell lines have been engineered through targeted gene editing techniques such as CRISPR/Cas9 to disrupt the EIF3K gene, allowing for the study of its functional implications in gene expression, protein synthesis, and cellular response to stress.

The primary function of EIF3K lies in its involvement in the assembly of the translation initiation complex, which is critical for the efficient initiation of protein synthesis. By utilizing these knockout cell lines, researchers can elucidate the specific contributions of EIF3K to translational control, revealing insights into mechanisms of cellular growth, differentiation, and apoptosis. Furthermore, the use of these cell lines can help identify potential therapeutic targets in diseases where translation dysregulation is a factor, including cancer and neurodegenerative disorders.

One of the key advantages of EIF3K Gene Knockout Cell Lines is their ability to provide a clean genetic background, free from the confounding effects of other EIF3 subunits or related proteins, ensuring that observed phenotypes are directly attributed to EIF3K deficiency. Compared to traditional methods of gene silencing, such as siRNA or shRNA, gene knockout provides a more permanent alteration, facilitating long-term studies and reducing the risk of off-target effects.

For researchers and clinicians, these knockout cell lines are invaluable in validating hypotheses about the role of EIF3K in cellular pathways and disease mechanisms, opening avenues for the development of novel therapeutic approaches. The ability to manipulate the EIF3K gene is particularly beneficial in understanding its potential role in translational dysregulation within tumor cells, making it a crucial asset for oncology research.

Our company prides itself on pioneering advanced genetic engineering technologies and providing high-quality biological products like the EIF3K Gene Knockout Cell Lines, backed by extensive expertise in molecular biology and cell biology. By equipping researchers with the tools they need to push the boundaries of scientific understanding, we empower innovation that has the potential to lead to groundbreaking discoveries and clinical advancements.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.